Log in

OTCMKTS:ARNIArno Therapeutics Stock Price, Forecast & News

0.00 (0.00 %)
(As of 07/10/2020 04:00 PM ET)
Today's Range
Now: $0.00
50-Day Range N/A
52-Week Range
Now: $0.00
Volume3,900 shs
Average Volume71,664 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Arno Therapeutics, Inc., a biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases. The company's product development pipeline includes Onapristone, a type 1 anti-progestin hormone blocker that is in Phase I/II clinical study for the treatment of breast, endometrial, and others solid tumors in post-menopausal women; and advanced castration-resistant prostate cancer in men. Its product development pipeline also consists of AR-12, an orally available cancer treatment, which has completed Phase I clinical study for the treatment of solid tumors and hematological malignancies, as well as in Pre-clinical studies for the treatment of various anti-microbial targets. In addition, the company's product development pipeline comprises AR-42, a novel orally available cancer therapy that is in Phase I investigator-initiated clinical study for the treatment of hematological malignancies and solid tumors. The company has license agreements with Invivis Pharmaceuticals, Inc.; the Regents of the University of Minnesota; and the Ohio State University Innovation Foundation, as well as a co-development agreement with Leica Biosystems Newcastle Ltd. Arno Therapeutics, Inc. is based in Flemington, New Jersey.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars

Industry, Sector and Symbol

Industry Biotechnology
Current SymbolOTCMKTS:ARNI



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive ARNI News and Ratings via Email

Sign-up to receive the latest news and ratings for ARNI and its competitors with MarketBeat's FREE daily newsletter.

Arno Therapeutics (OTCMKTS:ARNI) Frequently Asked Questions

How has Arno Therapeutics' stock been impacted by COVID-19 (Coronavirus)?

Arno Therapeutics' stock was trading at $0.0030 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ARNI shares have increased by 6.7% and is now trading at $0.0032. View which stocks have been most impacted by Coronavirus.

Has Arno Therapeutics been receiving favorable news coverage?

News coverage about ARNI stock has been trending very negative this week, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Arno Therapeutics earned a news sentiment score of -3.8 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news about Arno Therapeutics.

Who are some of Arno Therapeutics' key competitors?

Who are Arno Therapeutics' key executives?

Arno Therapeutics' management team includes the following people:
  • Mr. David M. Tanen J.D., Sec. & Director (Age 48)

What is Arno Therapeutics' stock symbol?

Arno Therapeutics trades on the OTCMKTS under the ticker symbol "ARNI."

How do I buy shares of Arno Therapeutics?

Shares of ARNI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Arno Therapeutics' stock price today?

One share of ARNI stock can currently be purchased for approximately $0.00.

What is Arno Therapeutics' official website?

The official website for Arno Therapeutics is www.arnothera.com.

How can I contact Arno Therapeutics?

Arno Therapeutics' mailing address is 200 State Route 31 Ste 104, FLEMINGTON, NJ 08822-5812, United States. The company can be reached via phone at +1-862-7037175.

This page was last updated on 7/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.